USE OF LIPOXYGENASE INHIBITORS AS ANTI-CANCER THERAPEUTIC AND INTERVENTION AGENTS - Patent 0750496

(19)

(11)

EP 0 750 496 A1

(12)

(43)	Date of publication:
	02.01.1997 Bulletin 1997/01

(21)	Application number: 95916100.0

(22)	Date of filing: 14.03.1995

(51)

International Patent Classification (IPC):

A61K 31/ 00^{( . )}
A61K 31/ 12^{( . )}
A61K 31/ 40^{( . )}
A61K 31/ 475^{( . )}

A61K 31/ 05^{( . )}
A61K 31/ 38^{( . )}
A61K 31/ 405^{( . )}

(86)	International application number:
	PCT/US1995/003337

(87)	International publication number:
	WO 1995/024894 (21.09.1995 Gazette 1995/40)

(84)	Designated Contracting States:
	AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

(30)

Priority:

14.03.1994 US 19940212074

(71)	Applicant: THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
	Rockville, MD 20852 (US)

(72)	Inventors:
	MULSHINE, James, L. Bethesda, MD 20817 (US) JETT, Marti Washington, DC 20010 (US)

(74)	Representative: VOSSIUS & PARTNER
	Siebertstrasse 4 81675 München 81675 München (DE)

(54)	USE OF LIPOXYGENASE INHIBITORS AS ANTI-CANCER THERAPEUTIC AND INTERVENTION AGENTS